Ironshore
More Ratings Needed
RepVue Score
Ironshore
Company Rank Pending
To ensure data accuracy, this profile must meet the following requirements to be ranked and receive a RepVue score and industry category rankings.
Rated by at least 4 unique users
At least 6 overall ratings
At least 70% verification score
Performance Category Ratings
See how employees rated Ironshore in RepVue’s key performance categories
This company profile must be ranked before it receives industry rankings and percentile scores.
Category Score
Industry Percentile
Industry Rank
Culture and Leadership
1.5
- th%of Pharma and Biotech orgs
# -of 15 Pharma and Biotech orgs
Base Compensation
4.0
- th%of Pharma and Biotech orgs
# -of 15 Pharma and Biotech orgs
Incentive Compensation Structure
2.5
- th%of Pharma and Biotech orgs
# -of 15 Pharma and Biotech orgs
Product - Market Fit
3.0
- th%of Pharma and Biotech orgs
# -of 15 Pharma and Biotech orgs
Professional Development and Training
2.5
- th%of Pharma and Biotech orgs
# -of 15 Pharma and Biotech orgs
Inbound Lead / Opportunity Flow
2.5
- th%of Pharma and Biotech orgs
# -of 15 Pharma and Biotech orgs
Diversity and Inclusion
2.5
- th%of Pharma and Biotech orgs
# -of 15 Pharma and Biotech orgs
About Ironshore
We are committed to the development and commercialization of first-in-class treatment options to improve the lives of patients and caregivers.
Employee Ratings
Total Employee Ratings
Total Ratings
?
Ratings Verified by RepVue
Verified Ratings
?
Frequently Asked Questions
Ironshore has an overall employee rating of 2.6 out of 5 and a RepVue score of null. They are ranked #null out of all Pharma and Biotech organizations.
Currently it is reported that 35.0% of the reps at Ironshore are hitting quota.
Ironshore has a rating of 1.5 out of 5 for culture and leadership. They are ranked #0 in this category out of 5696 companies.
Ironshore has a rating of 3.0 out of 5 for Product - Market Fit and is ranked #0 out of 15 Pharma and Biotech companies.
About Ironshore
We are committed to the development and commercialization of first-in-class treatment options to improve the lives of patients and caregivers.